Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

PKCα phosphorylation of RhoGDI2 at Ser31 disrupts interactions with Rac1 and decreases GDI activity.

Griner EM, Churchill ME, Brautigan DL, Theodorescu D.

Oncogene. 2013 Feb 21;32(8):1010-7. doi: 10.1038/onc.2012.124. Epub 2012 Apr 2.

2.

RhoC Is an Unexpected Target of RhoGDI2 in Prevention of Lung Colonization of Bladder Cancer.

Griner EM, Dancik GM, Costello JC, Owens C, Guin S, Edwards MG, Brautigan DL, Theodorescu D.

Mol Cancer Res. 2015 Mar;13(3):483-92. doi: 10.1158/1541-7786.MCR-14-0420. Epub 2014 Dec 16.

3.

RhoGDI2 is expressed in human trophoblasts and involved in their migration by inhibiting the activation of RAC1.

Liu S, Cui H, Li Q, Zhang L, Na Q, Liu C.

Biol Reprod. 2014 Apr 25;90(4):88. doi: 10.1095/biolreprod.113.111153. Print 2014 Apr.

PMID:
24554735
4.

Cholecystokinin-mediated RhoGDI phosphorylation via PKCα promotes both RhoA and Rac1 signaling.

Sabbatini ME, Williams JA.

PLoS One. 2013 Jun 11;8(6):e66029. doi: 10.1371/journal.pone.0066029. Print 2013.

5.

Assessment of roles for the Rho-specific guanine nucleotide dissociation inhibitor Ly-GDI in platelet function: a spatial systems approach.

Ngo AT, Thierheimer ML, Babur Ö, Rocheleau AD, Huang T, Pang J, Rigg RA, Mitrugno A, Theodorescu D, Burchard J, Nan X, Demir E, McCarty OJ, Aslan JE.

Am J Physiol Cell Physiol. 2017 Apr 1;312(4):C527-C536. doi: 10.1152/ajpcell.00274.2016. Epub 2017 Feb 1.

PMID:
28148498
6.

PKC mediates cyclic stretch-induced cardiac hypertrophy through Rho family GTPases and mitogen-activated protein kinases in cardiomyocytes.

Pan J, Singh US, Takahashi T, Oka Y, Palm-Leis A, Herbelin BS, Baker KM.

J Cell Physiol. 2005 Feb;202(2):536-53.

PMID:
15316932
7.

Rho GDP dissociation inhibitor 2 suppresses metastasis via unconventional regulation of RhoGTPases.

Moissoglu K, McRoberts KS, Meier JA, Theodorescu D, Schwartz MA.

Cancer Res. 2009 Apr 1;69(7):2838-44. doi: 10.1158/0008-5472.CAN-08-1397. Epub 2009 Mar 10.

8.

Src phosphorylation of RhoGDI2 regulates its metastasis suppressor function.

Wu Y, Moissoglu K, Wang H, Wang X, Frierson HF, Schwartz MA, Theodorescu D.

Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5807-12. doi: 10.1073/pnas.0810094106. Epub 2009 Mar 25.

9.

Rictor regulates cell migration by suppressing RhoGDI2.

Agarwal NK, Chen CH, Cho H, Boulbès DR, Spooner E, Sarbassov DD.

Oncogene. 2013 May 16;32(20):2521-6. doi: 10.1038/onc.2012.287. Epub 2012 Jul 9.

10.

Mechanisms of RhoGDI2 mediated lung cancer epithelial-mesenchymal transition suppression.

Niu H, Wu B, Jiang H, Li H, Zhang Y, Peng Y, He P.

Cell Physiol Biochem. 2014;34(6):2007-16. doi: 10.1159/000366396. Epub 2014 Nov 26.

11.

Interaction of protein kinase C isozymes with Rho GTPases.

Slater SJ, Seiz JL, Stagliano BA, Stubbs CD.

Biochemistry. 2001 Apr 10;40(14):4437-45.

PMID:
11284700
13.

RhoGDI2 expression in astrocytes after an excitotoxic lesion in the mouse hippocampus.

Yi MH, Kwon K, Zhang E, Seo JH, Kang SS, Son CG, Kang JW, Kim DW.

Cell Mol Neurobiol. 2015 Mar;35(2):167-74. doi: 10.1007/s10571-014-0108-z. Epub 2014 Oct 2.

PMID:
25274045
14.

MicroRNA-200b suppresses arsenic-transformed cell migration by targeting protein kinase Cα and Wnt5b-protein kinase Cα positive feedback loop and inhibiting Rac1 activation.

Wang Z, Humphries B, Xiao H, Jiang Y, Yang C.

J Biol Chem. 2014 Jun 27;289(26):18373-86. doi: 10.1074/jbc.M114.554246. Epub 2014 May 19.

15.

Mechanism of NADPH oxidase activation by the Rac/Rho-GDI complex.

Di-Poï N, Fauré J, Grizot S, Molnár G, Pick E, Dagher MC.

Biochemistry. 2001 Aug 28;40(34):10014-22.

PMID:
11513579
16.

RhoGDI2 is associated with HGF-mediated tumor invasion through VEGF in stomach cancer.

Koh SA, Kim MK, Lee KH, Kim SW, Kim JR.

Clin Exp Metastasis. 2014 Oct;31(7):805-15. doi: 10.1007/s10585-014-9671-4. Epub 2014 Sep 25.

PMID:
25253431
17.

The faces and friends of RhoGDI2.

Griner EM, Theodorescu D.

Cancer Metastasis Rev. 2012 Dec;31(3-4):519-28. doi: 10.1007/s10555-012-9376-6. Review.

PMID:
22718398
18.

An adventitious interaction of filamin A with RhoGDI2(Tyr153Glu).

Song M, He Q, Berk BA, Hartwig JH, Stossel TP, Nakamura F.

Biochem Biophys Res Commun. 2016 Jan 15;469(3):659-64. doi: 10.1016/j.bbrc.2015.12.044. Epub 2015 Dec 17.

19.

GDI-1 phosphorylation switch at serine 96 induces RhoA activation and increased endothelial permeability.

Knezevic N, Roy A, Timblin B, Konstantoulaki M, Sharma T, Malik AB, Mehta D.

Mol Cell Biol. 2007 Sep;27(18):6323-33. Epub 2007 Jul 16.

20.

VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance.

Cho HJ, Kim IK, Park SM, Baek KE, Nam IK, Park SH, Ryu KJ, Choi J, Ryu J, Hong SC, Jeong SH, Lee YJ, Ko GH, Kim J, Won Lee C, Soo Kang S, Yoo J.

Int J Cancer. 2014 Oct 1;135(7):1553-63. doi: 10.1002/ijc.28801. Epub 2014 Mar 4.

Supplemental Content

Support Center